Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Efficacy and safety of Changfu peritoneal dialysis solution: a multi-center prospective randomized controlled trial.

Zhou JH, Ni ZH, Mei CL, Yu XQ, Liu FY, Miao LN, Liu ZH, Yuan WJ, Zhang AP, Lin HL, Chen MH, Chen JH, Zhang JY, He YN, Chen J, Zhao JY, Ding XQ, Li Y, Li RS, Xie RJ, Liu WH, Xing CY, Wang R, Deng YY, Cao XY, Cai GY, Mou S, Mao ZG, Yang X, Liu H, Sun J, Yu YS, Liu J, Shi SM, Li LK, Tian N, Zhang XH, Zhou W, Yang J, Zhang Y, Sun JD, Ji J, Zhang T, Yan Y, Liu XG, Wang G, Zhang L, Zhang H, Luo JH, Chen XM.

Chin Med J (Engl). 2013 Nov;126(22):4204-9.

PMID:
24238498
2.

A multinational clinical validation study of PD ADEQUEST 2.0. PD ADEQUEST International Study Group.

Vonesh EF, Story KO, O'Neill WT.

Perit Dial Int. 1999 Nov-Dec;19(6):556-71.

PMID:
10641777
3.

Effects of intraperitoneal hyaluronan on peritoneal fluid and solute transport in peritoneal dialysis patients.

Moberly JB, Sorkin M, Kucharski A, Ogle K, Mongoven J, Skoufos L, Lin L, Bailey S, Rodela H, Mupas L, Walele A, Ogrinc F, White D, Wolfson M, Martis L, Breborowicz A, Oreopoulos DG.

Perit Dial Int. 2003 Jan-Feb;23(1):63-73.

PMID:
12691509
4.

Relationship between Kt/V urea-based dialysis adequacy and nutritional status and their effect on the components of the quality of life in incident peritoneal dialysis patients.

Chen JB, Lam KK, Su YJ, Lee WC, Cheng BC, Kuo CC, Wu CH, Lin E, Wang YC, Chen TC, Liao SC.

BMC Nephrol. 2012 Jun 14;13:39. doi: 10.1186/1471-2369-13-39.

5.

Increasing the dialysis volume and frequency in a fixed period of time in CPD patients: the effect on Kpt/V and creatinine clearance.

Juergensen PH, Murphy AL, Kliger AS, Finkelstein FO.

Perit Dial Int. 2002 Nov-Dec;22(6):693-7.

PMID:
12556071
6.

The plasma permeability factor in nephrotic syndrome: indirect evidence in pediatric peritoneal dialysis.

Azocar M, Quiroz L, Delucchi A, Dinamarca H, Emilfork M, Cano F.

Perit Dial Int. 2012 Jul-Aug;32(4):437-43. doi: 10.3747/pdi.2009.00251. Epub 2012 Apr 2.

7.

Frequency and causes of discrepancy between Kt/V and creatinine clearance.

Satko SG, Burkart JM, Bleyer AJ, Jordan JR, Manning T.

Perit Dial Int. 1999 Jan-Feb;19(1):31-7.

PMID:
10201338
8.

Could solutions low in glucose degradation products preserve residual renal function in incident peritoneal dialysis patients? A 1-year multicenter prospective randomized controlled trial (Balnet Study).

Kim SG, Kim S, Hwang YH, Kim K, Oh JE, Chung W, Oh KH, Kim HJ, Ahn C; Korean Balnet Study Group..

Perit Dial Int. 2008 Jun;28 Suppl 3:S117-22.

PMID:
18552239
10.

Clinical experience with a new bicarbonate (25 mmol/L)/lactate (10 mmol/L) peritoneal dialysis solution.

Otte K, Gonzalez MT, Bajo MA, del Peso G, Heaf J, Garcia Erauzkin G, Sanchez Tomero JA, Dieperink H, Povlsen J, Hopwood AM, Divino Filho JC, Faict D.

Perit Dial Int. 2003 Mar-Apr;23(2):138-45.

PMID:
12713080
11.

Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial.

Bonomini M, Di Liberato L, Del Rosso G, Stingone A, Marinangeli G, Consoli A, Bertoli S, De Vecchi A, Bosi E, Russo R, Corciulo R, Gesualdo L, Giorgino F, Cerasoli P, Di Castelnuovo A, Monaco MP, Shockley T, Rossi C, Arduini A.

Am J Kidney Dis. 2013 Nov;62(5):929-38. doi: 10.1053/j.ajkd.2013.04.007. Epub 2013 May 29.

PMID:
23725973
12.
13.

Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients.

Chung SH, Heimbürger O, Stenvinkel P, Qureshi AR, Lindholm B.

Nephrol Dial Transplant. 2003 Mar;18(3):590-7.

PMID:
12584284
14.
15.

Intermittent peritoneal dialysis: urea kinetic modeling and implications of residual kidney function.

Guest S, Akonur A, Ghaffari A, Sloand J, Leypoldt JK.

Perit Dial Int. 2012 Mar-Apr;32(2):142-8. doi: 10.3747/pdi.2011.00027. Epub 2011 Dec 1.

16.

A combination of biocompatible peritoneal dialysis solutions and residual renal function, peritoneal transport, and inflammation markers: a randomized clinical trial.

Lui SL, Yung S, Yim A, Wong KM, Tong KL, Wong KS, Li CS, Au TC, Lo WK, Ho YW, Ng F, Tang C, Chan TM.

Am J Kidney Dis. 2012 Dec;60(6):966-75. doi: 10.1053/j.ajkd.2012.05.018. Epub 2012 Jul 25.

PMID:
22835900
17.

A randomized clinical trial with a 0.6% amino acid/ 1.4% glycerol peritoneal dialysis solution.

Van Biesen W, Boer W, De Greve B, Dequidt C, Vijt D, Faict D, Lameire N.

Perit Dial Int. 2004 May-Jun;24(3):222-30.

PMID:
15185770
18.

Influence of peritoneal transport rate, inflammation, and fluid removal on nutritional status and clinical outcome in prevalent peritoneal dialysis patients.

Chung SH, Heimbürger O, Stenvinkel P, Wang T, Lindholm B.

Perit Dial Int. 2003 Mar-Apr;23(2):174-83.

PMID:
12713086
19.

Adequacy targets can be met in anuric patients by automated peritoneal dialysis: baseline data from EAPOS.

Brown EA, Davies SJ, Heimbürger O, Meeus F, Mellotte G, Rosman J, Rutherford P, Van Bree M; European Automated Peritoneal Dialysis Outcomes Study (EAPOS) Investigators..

Perit Dial Int. 2001;21 Suppl 3:S133-7.

PMID:
11887807
20.

The relationship between Kt/V(urea) and nPNA in anuric peritoneal dialysis patients: a comparison with predialysis patients.

Jansen MA, Korevaar JC, Dekker FW, Jager KJ, Boeschoten EW, Krediet RT; NESCOSAD Study Group. Netherlands Cooperative Study on the Adequacy of Dialysis..

Perit Dial Int. 2001 Sep-Oct;21(5):509-15.

PMID:
11757836

Supplemental Content

Support Center